Maureen Dillon

3.2k total citations · 1 hit paper
17 papers, 2.5k citations indexed

About

Maureen Dillon is a scholar working on Nephrology, Nutrition and Dietetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Maureen Dillon has authored 17 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 8 papers in Nutrition and Dietetics and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Maureen Dillon's work include Parathyroid Disorders and Treatments (12 papers), Magnesium in Health and Disease (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Maureen Dillon is often cited by papers focused on Parathyroid Disorders and Treatments (12 papers), Magnesium in Health and Disease (8 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Maureen Dillon collaborates with scholars based in United States. Maureen Dillon's co-authors include Steven K. Burke, Glenn M. Chertow, Scott Chasan-Taber, Naseem Amin, Paolo Raggi, Eduardo Slatopolsky, Eduardo A. Slatopolsky, Andrew T. Blair, Anthony J. Bleyer and D Fischer and has published in prestigious journals such as Journal of the American College of Cardiology, Kidney International and American Journal of Kidney Diseases.

In The Last Decade

Maureen Dillon

16 papers receiving 2.4k citations

Hit Papers

Cardiac calcification in adult hemodialysis patients 2002 2026 2010 2018 2002 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiac calcification in adult hemodialysis patients
    2002 922 citations Paolo Raggi, Scott Chasan-Taber et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen Dillon United States 12 2.0k 838 528 453 396 17 2.5k
Daniela Veit Barreto Brazil 22 2.1k 1.1× 584 0.7× 400 0.8× 356 0.8× 428 1.1× 34 3.1k
Masatomo Taniguchi Japan 27 1.9k 1.0× 394 0.5× 485 0.9× 350 0.8× 533 1.3× 109 2.7k
James V. Donadío United States 34 2.5k 1.3× 484 0.6× 482 0.9× 740 1.6× 710 1.8× 75 4.0k
Rachel M. Holden Canada 25 1.0k 0.5× 662 0.8× 250 0.5× 358 0.8× 229 0.6× 85 2.1k
Fabio Malberti Italy 21 1.3k 0.7× 173 0.2× 409 0.8× 525 1.2× 370 0.9× 48 2.0k
Simon D. Roger Australia 30 1.1k 0.6× 463 0.6× 224 0.4× 1.1k 2.5× 131 0.3× 88 3.7k
Bradley J. Maroni United States 26 2.0k 1.0× 327 0.4× 328 0.6× 268 0.6× 49 0.1× 41 3.1k
Ulrich Neyer Austria 21 1.2k 0.6× 250 0.3× 546 1.0× 182 0.4× 364 0.9× 32 2.1k
Soledad García de Vinuesa Spain 22 1.6k 0.8× 169 0.2× 718 1.4× 287 0.6× 519 1.3× 53 2.8k
James Ehrlich United States 17 704 0.4× 307 0.4× 324 0.6× 210 0.5× 206 0.5× 23 2.0k

Countries citing papers authored by Maureen Dillon

Since Specialization
Citations

This map shows the geographic impact of Maureen Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Dillon more than expected).

Fields of papers citing papers by Maureen Dillon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Dillon. The network helps show where Maureen Dillon may publish in the future.

Co-authorship network of co-authors of Maureen Dillon

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Dillon. A scholar is included among the top collaborators of Maureen Dillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Dillon. Maureen Dillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Murray, Stuart J., Mark T. Smith, Sunita Goyal, et al.. (2014). A randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on hemodialysis. International Journal of Nephrology and Renovascular Disease. 7. 141–141. 7 indexed citations
2.
Delmez, James A., Gilbert Block, John A. Robertson, et al.. (2007). A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis. Clinical Nephrology. 68(12). 386–391. 74 indexed citations
3.
Suki, Wadi N., Raja I. Zabaneh, José L. Cangiano, et al.. (2007). Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney International. 72(9). 1130–1137. 363 indexed citations
4.
Delmez, James A., Geoffrey A. Block, Anthony J. Bleyer, et al.. (2007). 48. American Journal of Kidney Diseases. 49(4). B36–B36. 2 indexed citations
5.
Fischer, D, Kenneth Cline, Melissa A. Plone, et al.. (2006). Results of a Randomized Crossover Study Comparing Once-Daily and Thrice-Daily Sevelamer Dosing. American Journal of Kidney Diseases. 48(3). 437–444. 13 indexed citations
6.
Burke, Steven K., et al.. (2003). Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients. Advances in Renal Replacement Therapy. 10(2). 133–145. 52 indexed citations
7.
Raggi, Paolo, Scott Chasan-Taber, Naseem Amin, et al.. (2002). Cardiac calcification in adult hemodialysis patients. Journal of the American College of Cardiology. 39(4). 695–701. 922 indexed citations breakdown →
8.
Dillon, Maureen, et al.. (2002). Artificial sunshine A social history of domestic lighting. OpenGrey (Institut de l'Information Scientifique et Technique). 2 indexed citations
9.
Chertow, Glenn M., Steven K. Burke, Maureen Dillon, & Eduardo Slatopolsky. (2000). Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients. Nephrology Dialysis Transplantation. 15(4). 559–559. 5 indexed citations
10.
Chertow, Glenn M., et al.. (2000). Hyperparathyroidism and dialysis vintage.. PubMed. 54(4). 295–300. 30 indexed citations
11.
Chertow, Glenn M., Maureen Dillon, Naseem Amin, & Steven K. Burke. (2000). Sevelamer with and without calcium and vitamin D: Observations from a long-term open-label clinical trial. Journal of Renal Nutrition. 10(3). 125–132. 17 indexed citations
12.
Davidson, Michael H., Maureen Dillon, Bruce R. Gordon, et al.. (1999). Colesevelam Hydrochloride (Cholestagel). Archives of Internal Medicine. 159(16). 1893–1893. 245 indexed citations
13.
Bleyer, Anthony J., Steven K. Burke, Maureen Dillon, et al.. (1999). A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. American Journal of Kidney Diseases. 33(4). 694–701. 204 indexed citations
14.
Slatopolsky, Eduardo A., Steven K. Burke, & Maureen Dillon. (1999). RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. Kidney International. 55(1). 299–307. 226 indexed citations
15.
Chertow, Glenn M., Steven K. Burke, Maureen Dillon, & Eduardo Slatopolsky. (1999). Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*. Nephrology Dialysis Transplantation. 14(12). 2907–2914. 215 indexed citations
16.
Chertow, Glenn M., Maureen Dillon, Anthony J. Bleyer, et al.. (1999). A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients.. PubMed. 51(1). 18–26. 102 indexed citations
17.
Dillon, Maureen, et al.. (1984). Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.. PubMed. 22(6). 285–93. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Veit Barreto Breakdown of academic impact, for papers by Masatomo Taniguchi Breakdown of academic impact, for papers by James V. Donadío Breakdown of academic impact, for papers by Rachel M. Holden Breakdown of academic impact, for papers by Fabio Malberti Breakdown of academic impact, for papers by Simon D. Roger Breakdown of academic impact, for papers by Bradley J. Maroni Breakdown of academic impact, for papers by Ulrich Neyer Breakdown of academic impact, for papers by Soledad García de Vinuesa Breakdown of academic impact, for papers by James Ehrlich
Rankless by CCL
2026